Phase I Clinical and Pharmacological Studies of 20‐(S)‐Camptothecin and 20‐(S)‐9‐Nitrocamptothecin as Anticancer Agents
- 17 December 1996
- journal article
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 803 (1) , 224-230
- https://doi.org/10.1111/j.1749-6632.1996.tb26392.x
Abstract
Click on the article title to read more.Keywords
This publication has 7 references indexed in Scilit:
- Conversion of 9‐nitro‐camptothecin to 9‐amino‐camptothecin by human blood cells in vitroEuropean Journal of Haematology, 1994
- Marked Interspecies Variations Concerning the Interactions of Camptothecin with Serum Albumins: A Frequency-Domain Fluorescence Spectroscopic StudyBiochemistry, 1994
- The Current Status of Camptothecin Analogues as Antitumor AgentsJNCI Journal of the National Cancer Institute, 1993
- DNA Topoisomerases as Anticancer Drug TargetsPublished by Elsevier ,1990
- Modification of the hydroxylactone ring of camptothecin: inhibition of mammalian topoisomerase I and biological activityJournal of Medicinal Chemistry, 1989
- Alkaloids of Mappia foetidaPhytochemistry, 1972
- Plant Antitumor Agents. I. The Isolation and Structure of Camptothecin, a Novel Alkaloidal Leukemia and Tumor Inhibitor from Camptotheca acuminata1,2Journal of the American Chemical Society, 1966